Skip to main content
Log in

Pattern of111in-chloride bone marrow scintigraphy in myelodysplastic syndrome; comparison with clinical characteristics

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

111In-chloride bone marrow scintigraphy (bone marrow scintigraphy) was performed in patients with myelodysplastic syndrome (MDS), tracer accumulation was classified into patterns, and the relationship between the accumulation patterns and prognostic factors was investigated to assess the usefulness of bone marrow scintigraphy.

The subjects were 14 patients diagnosed with MDS. Accumulation of the bone marrow scintigraphy tracer was classified according to the degree of accumulation in the axial bone marrow and peripheral expansion. International Prognostic Scoring System (IPSS), which are frequently used for prognostic evaluation of MDS, and conversion to leukemia were investigated in prognostic factors. We also investigated the relationship between enlargement of the liver and spleen and the prognostic factors.

The accumulation patterns were as follows: pattern I, The normal accumulation pattern (2 cases); pattern II, the expanded accumulation pattern (6 cases); pattern III, low accumulation pattern (5 cases); and pattern IV, heterogeneous accumulation pattern (1 case). The relationships between the two prognostic factors and accumulation patterns were investigated, and the prognosis was found to be significantly poorer in the patients with the low accumulation pattern than the expanded accumulation pattern. Enlargement of the liver and spleen was not significantly correlated with the prognostic factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Nalean Y, Le Canvic M, Le Meercier N, Pecking A, Colonna P, Rain JD. Significance of bone-marrow scintig- raphy in aplastic anemia.J Nucl Med 1980; 21: 213–218.

    Google Scholar 

  2. Fujishima M, Hiraki Y, Takeda Y, Kohno Y, Niiya H, Aono K, et al. Bone marrow scintigraphy with111In-chloride—a clinical value for the hematological diseases.Radioisotopes 1988; 37 (10): 552–557.

    Google Scholar 

  3. Takada T, Ino T, Kojima H, Maruyama F, Sobue R, Itou N, et al. Assessment of bone marrow hematopoietic activity in aplastic anemia by point-counting method in relation to the clinical status and prognosis.Jpn J Clin Hematol 1987; 28 (6): 823–829.

    Google Scholar 

  4. Pauwels EK, Hermans J, Jurgens PJ, Tjon Pian Gi CE, Haak HL, te Velde J. Scintigraphic aspects of111In-chloride bone marrow scintigraphy in aplastic anaemia.Diagn Imaging 1981; 50(5): 269–276.

    CAS  PubMed  Google Scholar 

  5. Koizumi M, Goto M, Nomura T, Watari T, Saito K. Evaluation of renal uptake on111InCl3bone marrow scintigraphy in patients with aplastic anemia and myelodysplastic syndrome.KAKU IGAKU (Jpn J Nucl Med) 1993; 30(4): 377–387.

    CAS  Google Scholar 

  6. Hiraki Y, Niiya H, Yamamoto Y, Watari T, Saito K. Significance of renal high uptake in bone marrow scintigraphy with In-111 chloride.Radioisotope 1987; 36: 409–413.

    CAS  Google Scholar 

  7. Greenberg P, Cox C, Le Beau MM. International scoring system for evaluating prognosis in myelodysplastic syndromes.Blood 1997; 89: 2079–2088.

    CAS  PubMed  Google Scholar 

  8. Ohtake E, Murata H. Nuclear imaging in hematology.Jpn J Pediatr Surg 1991; 23 (10): 1125–1129.

    Google Scholar 

  9. Mabuchi N, Kumano M, Fumiko M, Arita S, Nakagawa K, Fujii K, et al. Bone marrow scintigraphy using indium-111 chloride in patients with aplastic anemia.Med J Kinki Univ 1987; 12 (4): 643–649.

    Google Scholar 

  10. Sale BA, Helmer RE 3rd, Birdsong BA, Balachandran S, Gardner FH. Bone-marrow imaging with indium-111 chloride in aplastic anemia and myelofibrosis: concise communication.J Nucl Med 1982; 23 (2): 121–125.

    Google Scholar 

  11. Horn NL, Bennett LR, Marciano D. Evaluation of aplastic anemia with indium chloride In 111 scanning.Arch Intern Med 1980; 140 (10): 1299–1303.

    Article  CAS  PubMed  Google Scholar 

  12. McNeil BJ, Holman BL, Button LN, Rosenthal DS. Use of indium chloride scintigraphy in patients with myelofibrosis.J Nucl Med 1974; 15 (8): 647–651. No abstract available.

    CAS  PubMed  Google Scholar 

  13. Edward H, Gilbert M, Glatstein M, Michael L, Goris M, John D, et al. Value of Indium-111 chloride bone marrow scanning in the differential diagnosis of blood count depression in lymphoma.Cancer 1978; 41: 143–152.

    Article  Google Scholar 

  14. Imai Y, Asakura Y, Kinoshita M, Sueyoshi T, Eguchi Y, Oota S, et al. Disseminated bone marrow metastases from gastric cancer: detection and monitoring the effectiveness of chemotherapy by bone marrow scintigraphy.KAKU IGAKU (Jpn J Nucl Med) 2001; 38 (3): 237–240.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takako Nakai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakai, T., Okuyama, C., Kubota, T. et al. Pattern of111in-chloride bone marrow scintigraphy in myelodysplastic syndrome; comparison with clinical characteristics. Ann Nucl Med 18, 675–680 (2004). https://doi.org/10.1007/BF02985961

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02985961

Key words

Navigation